Wolv:"Very positive message on the R&D section for all their drugs, and its not just spin."And you know that..... how?
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
TLS Telstra to boost phone plan prices despite inflation – and despite claiming they wouldn't 2 months ago